Last updated on April 2019

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)

Brief description of study

An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Detailed Study Description


To evaluate the long-term safety and tolerability of seladelpar


To evaluate the long-term efficacy of seladelpar

Clinical Study Identifier: NCT03301506

Find a site near you

Start Over

Henry Ford Health System

Novi, MI United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.